FAM
RMD icon

Fenimore Asset Management’s ResMed RMD Stock Holding History

Fenimore Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,450
Closed -$3.73M – 111
2020
Q2 		$3.73M Hold
19,450
– – 0.13% 73
2020
Q1 		$2.87M Buy
+19,450
New +$3.1M 0.12% 76

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fenimore Asset Management's RMD Position: Q3 2020 in Review

Fenimore Asset Management sold out of ResMed (RMD) in Q3 2020, closing a stake of 19,450 shares — an estimated $3.73M sold.

Fenimore Asset Management first reported a position in RMD in Q1 2020 and held it in 2 quarters. The position peaked at $3.73M in Q2 2020. 627 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Fenimore Asset Management reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Fenimore Asset Management sold 19,450 ResMed shares in Q3 2020, an estimated $3.73M.
  • Fenimore Asset Management first reported a position in ResMed in Q1 2020 and held it in 2 quarters.
  • Fenimore Asset Management's ResMed position peaked at $3.73M in Q2 2020.
  • 627 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Fenimore Asset Management's 13F filing for Q3 2020, filed 13 Oct 2020.